Local recurrence or cardiovascular disease: Pay now or later

Journal of the National Cancer Institute

Volumn 99, Issue 5, 2007, Pages 340-341

  Giordano, Sharon H ^a   Hortobagyi, Gabriel N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TRASTUZUMAB;

BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; EDITORIAL; FATALITY; HEART DEATH; HEART INFARCTION; HODGKIN DISEASE; HUMAN; ISCHEMIC HEART DISEASE; LUNG CANCER; MASTECTOMY; MORBIDITY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RISK REDUCTION; VALVULAR HEART DISEASE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST TUMOR; COHORT ANALYSIS; EPIDEMIOLOGY; FEMALE; FOLLOW UP; HEART DISEASE; METHODOLOGY; NETHERLANDS; NOTE; STATISTICS; SURVIVOR; TUMOR RECURRENCE;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HEART FAILURE, CONGESTIVE; HEART VALVE DISEASES; HUMANS; MYOCARDIAL INFARCTION; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; RADIOTHERAPY, ADJUVANT; RESEARCH DESIGN; SURVIVORS;

EID: 33947716579     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djk085     Document Type: Editorial

References (12)

1. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005;366:2087-106.
2. Paszat LF, Mackillop, WJ, Groome PA, Boyd C, Schulze K, Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 1998;16:2625-31.
3. Paszat LF, Mackillop WJ, Groome PA, Schulze K, Holowaty E. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: A population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 1999;43:755-62.
4. Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 1992;22:887-96.
5. Rutqvist LE, Johansson H. Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer 1990;61:866-8.
6. Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994; 12:447-53.
7. Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005;97:419-24.
8. Darby S, McGale P, Peto R, Granath F, Hall P, Ekbom A. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: Nationwide cohort study of 910000 Swedish women. BMJ 2003;326:256-7.
9. Hooning MJ, Botma A, Aleman BMP, Baaijens MHA, Bartelink H, Khijn JGM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 2007;99:365-75.
10. Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005;6:557-65.
11. Patt DA, Goodwin JS, Kuo YF, Freeman JL, Zhang DD, Buchholz TA, et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 2005;23:7475-82.
12. Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 2004;22:3139-48.